Detecting Improvement in Quality of Life and Symptomatology in Schizophrenia

Schizophrenia Bulletin

Volumn 27, Issue 2, 2001, Pages 227-234

  Cramer, Joyce ^a   Rosenheck, Robert ^d   Xu, Weichun ^c   Henderson, William ^c   Thomas, Jonathan ^c   Charney, Dennis ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d NONE

Author keywords

Clinical trial; Clozapine; Haloperidol; Quality of life; Schizophrenia

Indexed keywords

CLOZAPINE; HALOPERIDOL;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; STATISTICS; VETERAN;

ADULT; CLOZAPINE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HALOPERIDOL; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VETERANS;

EID: 0035228691     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a006869     Document Type: Article

References (26)

1. Atkinson, M.; Zibin, S.; and Chuang, H. Characterizing quality of life among patients with chronic mental illness: A critical examination of the self-report methodology. American Journal of Psychiatry, 154:99-105, 1997.
2. Barber, B.L.; Santanello, N.C.; and Epstein, R.S. Impact of the global on patient perceivable change in an asthma specific QOL questionnaire. Quality of Life Research, 5:117-122, 1996.
3. Beck, A.T.; Ward, C.H.; Mendelson, M.; Mock, J.; and Erbaugh, J. An inventory for measuring depression. Archives of General Psychiatry, 4:561-571, 1961.
4. Cicchetti, D.V.; Rosenheck, R.; Showalter, D.; Cramer, J.; and Charney, D. Interrater reliability levels of multiple clinical examiners in the evaluation of a schizophrenic patient: Quality of life, level of functioning, and neuropsychological symptomatology. The Clinical Neuropsychologist, 13:157-170, 1999.
5. Cicchetti, D.V.; Showalter, D.; and Rosenheck, R. A new method for examining inter-examiner agreement when multiple ratings are made on a single subject: Applications to the assessment of neuro-psychiatric symptomatology. Psychiatry Research, 72:51-63, 1997.
6. Cramer J.A.; Rosenheck R.; Xu W.; Henderson W.; Thomas J.; and Charney D., for the Department of Veterans Affairs Cooperative Study on Clozapine in Refractory Schizophrenia. Detecting improvement in symptomatology and quality of life in schizophrenia. Schizophrenia Bulletin, 26:659-666, 2000.
7. Cramer, J.A., and Spilker, B. Quality of Life and Pharmacoeconomics: An Introduction. Philadelphia, PA: Lippincott-Raven Publishers, 1998.
8. Guyatt, G.H.; Juniper, E.F.; Walter, S.D.; Griffith, L.E.; and Goldstein, R.S. Interpreting treatment effects in randomized trials. British Medical Journal, 316:690-693, 1998.
9. Hamilton, M. Rating depressive patients. Journal of Clinical Psychiatry, 41:21-24, 1980.
10. Hays, R.D.; Vickrey, B.V.; Hermann, B.P.; Perrine, K.; Cramer, J.A.; Meador, K.; Spritzer, K.; and Devinsky, O. Agreement between self-reports and proxy reports of quality of life in epilepsy patients. Quality of Life Research, 4:159-168, 1995.
11. Heinrichs, D.W.; Hanlon, T.E.; and Carpenter, W.T. The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10(3):388-398, 1984.
12. Jaeschke, R.; Singer, J.; and Guyatt, G.H. Measurement of health status. Controlled Clinical Trials, 10:407-415, 1989.
13. Juniper, E.F.; Guyatt, G.H.; Willan, A.; and Griffith, L.E. Determining a minimal important change in a disease-specific quality of life questionnaire. Journal of Clinical Epidemiology, 47:81-87, 1994.
14. Kay, S.R.; Fizbein, A.; and Opler, L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2):261-276, 1987.
15. Lehman, A.F. The quality of life interview for the chronically mentally ill. Evaluation and Program Planning, 11:51-62, 1988.
16. Lehman, A.F. Measures of quality of life among persons with severe and persistent mental disorders. Social Psychiatry and Psychiatric Epidemiology, 31:78-88, 1996.
17. Opler, L.A., and Ramirez, P.M. Structured Clinical Interview for the PANSS (SCI-PANSS). Toronto, Canada: Multi-Health Systems, 1992.
18. Osoba, D.; Rodrigues, G.; Myles, J.; Zee, B.; and Pater, J. Interpreting the significance of changes in heath-related quality of life scores. Journal of Clinical Oncology, 16:139-144, 1988.
19. Overall, J.E., and Gorham, D.R. The Brief Psychiatric Rating Scale. Psychology Reports, 10:799-812, 1962.
20. Redelmeier, D.A.; Guyatt, G.H.; and Goldstein, R.S. Assessing minimal important difference in symptoms: A comparison of two techniques. Journal of Clinical Epidemiology, 49:1223-1224, 1996.
21. Rosenheck, R.; Cramer, J.; Xu, W.; Thomas, J.; Henderson, W.; Frisman, L.; Fye, C.; and Charney, D.S., for the DVA Cooperative Study Group on Clozapine in Refractory Schizophrenia. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. New England Journal of Medicine, 337:809-815, 1997.
22. Sen, A. Inequality Reexamined. Cambridge, MA: Harvard University Press, 1992.
23. Strauss, J., and Carpenter, W.T. Prediction of outcome in schizophrenia: III. Five year outcome and its predictors. Archives of General Psychiatry, 34:159-163, 1977.
24. Teasdale, G., and Jennett, B. Assessment of coma and impaired consciousness: A practical scale. Lancet, 2:81-84, 1974.
25. Tollefson, G.D.; Beasley, C.M.; Tran, P.V.; Street, J.S.; Krueger, J.A.Q.; Tamura, R.N.; Graffeo, K.A.; and Thieme, M.E. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial. American Journal of Psychiatry, 154:457-465, 1997.
26. Weibe, S.; Deny, P.A.; and McLachlin, R.S. In search of a minimum clinically important change in epilepsy: Specific quality of life instruments. Epilepsia, 38 (Suppl 8):83, 1997.